In a multicentre study on infected, 11/26 (42-3%) second born children were also infected, whereas this happened in only 2/16 (12-5%) second or third born children when the first born was uninfected. Two out of nine first born (22-r/o) and 5/21 (23-8%) second born children prospectively followed up from birth acquired the infection. Results of this study demonstrate that neither twin nor second pregnancies arg at increased risk of mother to child HIV-I transmission. Overall data suggest that non-casual factors in mother and/or child influence perinatal infection.
Transmission from the mother to her offspring accounts for most cases of human imunodeficiency virus type I (HIV-I) infection in children.' 2 Transmission occurs mostly in utero,3 but intrapartum exposure to maternal blood and vaginal fluid4 5 or breast feeding2 6 may be additional routes. Results oflarge studies on efficiency of mother to child transmission have been recently reviewed. 2 The risk of vertical transmission of HIV-I in twin or second pregnancies has not yet been defined. Reports on twins7'9 are anecdotal and studies in siblings contain selection biasl' or are based on very limited series.'2 13 (P-0) . In 18 pairs the infection status was known, including 10 pairs prospectively followed up from birth.
In the group of twins with known infection status (18 boys and 18 girls aged 16-3 months at the last follow up, range 3-1-60-7 months), nine of the (25%) children were infected. Sex and/or blood and/or HLA typing differed in eight pairs. A reasonable presumption of monozygosity was made in five pairs, whereas zygosity was uncertain in five pairs. Concordance in infection status according to zygosity is reported in table 1. The relative risk of infection in one twin when the other was infected was 23-1 (95% confidence interval 3-3 to 162-1; p<0-00001). Infected and uninfected pairs differed neither in gestational age (36-6 (3-1) compared with 35-1 (2-1) weeks) nor frequency of vaginal delivery (2/4, 50% compared with 7/13, 54%). Frequency ofinfected pairs among those born at a gestational age less than 36 weeks (1/5, 20%) was comparable with that observed in pairs born at or after 36 weeks (3/12, 25%). Birth weight was similar in infected (2167 (336) g) and uninfected (2144 (373) g) twins. In contrast, the proportion of breast fed subjects was significantly higher in infected than in uninfected twins (5/9, 56% compared with 1/27, 4%; p=0 002).
Age at last check in infected children was 26 months (range 6-60 months). All HIV-I infected -^hildren (two P-1 pairs, two P-2 pairs, and one dditional P-2 patient) were surviving. In one of 10 (10%) pairs prospectively followed up from birth both twins were HIV-I positive. Six pairs (60%) were born by caesarean section, with a frequency comparable with that observed in the whole group. None had been breast fed.
SIBLINGS
Fifty six out of 1415 (3-9%) seropositive women had more than one pregnancy and 115 children (68 boys and 47 girls) were born (including one first born twin pair, one second born twin pair, and one third born child). The presence of HIV-I related clinical manifestations was recorded in four primiparous women and in five women at second delivery.
Infection status was defined in 41 sibshipsthat is, 84 children inclusive of one first born twin pair and one third born child. This group included 22 boy and 20 girl first born children aged at the last follow up 38-1 months (range 4 9-93 9) and 30 boy and 12 girl second or third born children aged 16-3 months (range 3-1-60-7). Nine first and 21 second or third born children had been prospectively followed up from birth.
Considering all sibships with known infection status, 26/42 (61 9%) first born and 13/42 (30 9%) second or third born children were infected. On the other hand, when subjects prospectively followed up from birth were taken into account, the presence of infection was reported in an equal proportion of first (2/9, 22-2%) and second or third (5/21, 23-8%) children.
The frequencies of sibships that were concordant or discordant in infection status is reported in table 2. The large majority of discordant sibships included an infected first born and an uninfected second born child. Considering these results from a different point of view (table 3) , it was observed that the frequency of infected second born children was significantly higher when the first born was infected than when the first child was uninfected. A 3-1 (95% confidence interval 0-8 to 12-4) relative risk of infection in second born was observed (when the first born was infected) with an at limit significance (p=0 054). Information on gestational age, birth weight, type of delivery, and feeding was available in 78 children. Results were comparable in first and second born infected or uninfected children (table 4). The overall frequency of breast feeding, however, was significantly higher in infected (17/36 , 47 2%) than in uninfected (9/ 42, 21-4%; p=0-03) siblings.
The frequency of subjects classified as P-2 was comparable in first born (21/26 , 80 7%) and second born (10/13, 76 9%) infected children, and no difference was observed as to age at onset of symptoms (15 months, range 1-65 months and 13-5 months, range 1-65 months, respectively). Considering the 11 infected sibling pairs, clinical outcome overlapped in seven (64%) instances (one P-1 pair and six P-2 pairs). On the other hand, an increased frequency of breast fed children was observed in infected subjects. This finding is interesting but a selection bias cannot be ruled out. In fact, very few children identified at birth had been breast fed, as in our country most centres counsel bottle feeding for at risk infants. The small number of mothers who were symptomatic at delivery prevented us from considering the role of this variable in favouring vertical transmission. However, it is noteworthy that an equally low proportion of symptomatic women was recorded at first and second delivery suggesting that progression of clinical manifestations after pregnancy is not the rule. 27 Our results lead us to speculate that some non-casual factor(s) in the mother and/or the child are crucial in favouring or preventing perinatal HIV-I infection. The role of maternal antibodies to discrete domains of gpl20 has been shown.23 24 The role of polymorphisms in HIV-I disease progression has been suggested,28 but whether they also influence susceptibility to infection remains to be defined.
